Rajesh K. Kharbanda

Featured in: Favicon

medscape.com Favicon

oxfordjournals.org Favicon

onlinejacc.org Favicon

citoday.com Favicon

eurheartj.oxfordjournals.org Favicon

interventions.onlinejacc.org

Articles

Routine cerebral embolic protection shows no benefit for patients undergoing TAVR

3 weeks ago | healio.com | Erik Swain |Katie Kalvaitis |B. Hadley Wilson |Rajesh K. Kharbanda

• Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve replacement. • The future of routine cerebral embolic protection in TAVR is in question. CHICAGO — Routine cerebral embolic protection did not reduce the incidence of stroke at 72 hours in patients undergoing transcatheter aortic valve replacement, according to results of the BHF PROTECT-TAVI trial.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →